-->

2022 AAB Conference & CRB Symposium
May 11-14, 2022 • Austin, Texas


NEW Health and Safety Information: AAB/CRB 3-Phase COVID Safety Plan

AAB’s highest priority is the health and safety of attendees, participants, staff, and our communities. To help ensure the health and safety of all, AAB/CRB has developed a 3-Phase COVID Safety Plan for the 2022 Conference/Symposium. The safety plan will continue to be reviewed and updated as needed to comply with current facility requirements, Centers for Disease Control and Prevention guidelines, state and local restrictions and guidelines, and event industry best practices at the time of the event. Please continue to check back and review the 3-Phase COVID Safety Plan for any updates prior to attending the event.


AAB/CRB 3-Phase COVID Safety Plan (as of 3/2/22)

Note: Attendees and participants will NOT be allowed to attend any Conference/Symposium activity without a signed AAB attestation form, and attendees/participants MUST meet at least one of the pre-registration requirements listed in Phase I.


Phase I – Before registration and admittance to any functions, provide ONE of the following:

OR

  • Proof of COVID test within three (3) days of attending the conference – either antigen or PCR [see acceptable documentation]. A limited supply of at-home COVID antigen tests will be available at the conference.

Phase II – At registration, before attending any functions:

  • Complete a COVID attestation form stating that you are not ill and that you have not, to your knowledge, been recently exposed to anyone who is ill [see AAB COVID Attestation Form]. Excludes medical personnel in situations where appropriate PPE is worn.
  • Masks are recommended but not required. Mask requirements will follow CDC recommendations for Travis County, TX.

Phase III – Each day before attending any function:

  • Have a daily temperature check conducted by AAB staff and obtain a daily color-coded sticker/band for easy identification.

Quick Links


AAB/CRB COVID Safety Plan Details and Requirements

Phase I – Before registration and admittance to any functions, provide ONE of the following options:

Option A: Proof of Vaccination:

You are considered fully vaccinated:

  • 2 weeks (14 days) after your dose of an accepted single-dose vaccine
  • 2 weeks (14 days) after your second dose of an accepted 2-dose series
  • 2 weeks (14 days) after you received the full series of an accepted COVID-19 vaccine (not placebo) in a clinical trial
  • 2 weeks (14 days) after you received 2 doses of any “mix-and-match” combination of accepted COVID-19 vaccines administered at least 17 days apart

Documentation of COVID Vaccination

  • Printout of COVID-19 vaccination record or a COVID-19 vaccination certificate issued at national or subnational level or by an authorized vaccine provider (e.g., the CDC vaccination card)
  • Vaccination certificate with QR code, digital pass via Smartphone application with QR code (e.g., United Kingdom National Health Service COVID Pass, European Union Digital COVID Certificate)
  • Digital photos of vaccination card or record downloaded vaccine record or vaccination certificate from an official source (e.g., public health agency, government agency, or other authorized vaccine provider), or a mobile phone application without QR code

Documentation must include the following:

  • Personal identifiers (full name plus at least one other identifier such as date of birth)
  • Name of official source issuing the record (e.g., public health agency, government agency, or other authorized vaccine provider)
  • Vaccine manufacturer and date(s) of vaccination

OR

Option B: Proof of COVID Infection Within Six (6) Months of the Conference:

Documentation of prior infection may be either a positive laboratory test report or documentation from your healthcare provider (see requirements below).

  • Documentation of a positive COVID test result
    • Includes the name of the individual tested
    • Date of the test (must be within six [6] months of attending the conference)
    • Be a CLIA acceptable clinical laboratory report
    • Show the name, address, and phone number of the laboratory performing the test
  • Documentation from healthcare provider must meet the following:
    • Include the name of the individual with COVID
    • Date of infection (must be within six [6] months of attending the conference)
    • Be on the letterhead of the healthcare provider or associated clinic/hospital
    • Be signed by the healthcare provider
    • Show the name, address, and phone number of the healthcare provider
    • Include a statement that the individual has completed the appropriate period of self-isolation and has been cleared to reenter society.

OR

Option C: Proof of Negative COVID Test:

A test result must be in the form of written documentation (paper or digital copy). The documentation must include:

  1. Type of test (indicating it is a NAAT or antigen test). The test must be a SARS-CoV-2 viral test (nucleic acid amplification test [NAAT] or antigen test) with Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) OR the relevant national authority where the test is administered. If the test is an at-home administered antigen test, it must meet the following requirements in addition to the others listed here.
    • The testing procedure must include a telehealth service affiliated with the manufacturer of the test that provides real-time supervision remotely through an audio and video connection. Some FDA-authorized self-tests that include a telehealth service may require a prescription.
    • The telehealth provider must confirm your identity, observe the sample collection and testing procedures, confirm the test result, and issue a report that meets the requirements listed here.
  2. The entity issuing the result (e.g., laboratory, healthcare entity, or telehealth service)
  3. Sample collection date - A negative test result must show the sample was taken no more than three (3) days before the conference.
  4. Information that identifies the person (full name plus at least one other identifier such as date of birth or passport number)
  5. Negative Test result

Phase II – At registration, before attending any functions, all attendees and participants must:

  • Complete and sign an AAB Attestation Form upon arrival at the event
  • Satisfy the Phase I requirement
  • Must not be experiencing any symptoms of illness, and have no known exposures to individuals who have been experiencing symptoms of illness or have tested positive for COVID-19. Excludes medical personnel in situations where appropriate PPE is worn.

Click here to review the AAB Attestation Form (pdf).

Note: Attendees and participants will NOT be allowed to attend any Conference/Symposium without a signed AAB attestation form and having met at least one of the required pre-registration requirements listed in Phase I.


Phase III – Each day before attending any function

Participants will be required to have their temperature checked once each day before attending any function. A designated area outside of meeting and registration areas will be set up for this purpose. Participants will obtain a color-coded wristband or sticker to verify their temperature has been taken.


Additional Health and Safety Measures


Personal Protective Equipment (PPE)

Face masks are strongly recommended, particularly when in close proximity to fellow attendees, participants, or staff, and will be available onsite.


Physical Distancing

Additional space will be added to Conference/Symposium functions where possible.


Cleaning and Hygiene

Hand sanitizer will be provided to attendees and participants at various locations throughout the Conference/Symposium.


AT&T Hotel and Conference Center

The AT&T Hotel and Conference Center has implemented health and safety protocols in collaboration with UT healthcare experts and industry guidelines.

Click here to download and view the AT&T Hotel and Conference Center Health and Safety Plan (pdf) or visit the hotel website’s Health and Safety Information.


Austin, Texas

Click here to learn more about Austin’s current reopening status and health and safety measures: COVID-19 in Austin.


Revised March 3, 2022

 

Thank You to the 2022 Sponsors

Platinum Sponsors


HT

HT

Cryos

HT


Gold Sponsors


/    


Silver Sponsors


Bronze Sponsors



Sponsors as of 4/15/22.

Other Sites of Interest

Clients Logo
Clients Logo
Clients Logo
Clients Logo
Clients Logo
Clients Logo
Clients Logo